Bridgecreek Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-144,610	Closed	-$18.7M	–	121
2021 Q4	$18.7M	Sell	144,610 -75	-0.1%	-$8.75K	2.56%	12
2021 Q3	$16.4M	Sell	144,685 -605	-0.4%	-$69.1K	2.34%	13
2021 Q2	$15M	Sell	145,290 -13,965	-9%	-$1.32M	2.19%	15
2021 Q1	$13.3M	Sell	159,255 -1,410	-0.9%	-$119K	2.06%	15
2020 Q4	$14.7M	Buy	160,665 +1,350	+0.8%	+$112K	2.22%	16
2020 Q3	$12.7M	Buy	159,315 +120	+0.1%	+$9.36K	2.23%	15
2020 Q2	$11M	Buy	159,195 +120	+0.1%	+$8.53K	2.06%	15
2020 Q1	$10M	Buy	159,075 +3,975	+3%	+$287K	2.59%	13
2019 Q4	$12.1M	Buy	155,100 +225	+0.1%	+$17.6K	2.19%	12
2019 Q3	$11.4M	Buy	154,875 +1,140	+0.7%	+$80.1K	2.36%	10
2019 Q2	$9.47M	Buy	153,735 +465	+0.3%	+$28.1K	1.98%	15
2019 Q1	$9.78M	Buy	153,270 +2,655	+2%	+$152K	2.07%	13
2018 Q4	$7.69M	Sell	150,615 -1,485	-1%	-$75.1K	2.05%	14
2018 Q3	$8.83M	Buy	152,100 +630	+0.4%	+$30.8K	1.76%	16
2018 Q2	$7.35M	Buy	151,470 +1,500	+1%	+$70K	1.6%	22
2018 Q1	$6.97M	Buy	149,970 +3,075	+2%	+$134K	1.57%	22
2017 Q4	$5.52M	Buy	146,895 +11,985	+9%	+$440K	1.3%	31
2017 Q3	$4.92M	Buy	134,910 +8,025	+6%	+$306K	1.34%	33
2017 Q2	$5M	Buy	126,885 +17,250	+16%	+$630K	1.34%	36
2017 Q1	$3.44M	Buy	109,635 +32,100	+41%	+$1M	0.93%	50
2016 Q4	$2.42M	Buy	+77,535	New	+$2.51M	0.68%	57